About Sasaeah Pharmaceutical
Sasaeah Pharmaceutical is a Healthcare company based in Shinagawa (Japan) founded in 2020, and was acquired by Virbac in March 2024. Sasaeah Pharmaceutical is engaged in animal health product distribution. It operates on a Reseller / Distribution and Subscription Services model. Its chief executive, as recorded, is Shigeru Taniguchi. Sasaeah Pharmaceutical offers products and services including Vaccines, Therapeutic Drugs, and Dosage Reminder Service. Its focus areas include Veterinary Medicine and Animal Pharmaceuticals. Its legal entity is Sasaeah Pharmaceutical Co., Ltd.
Company details
Sasaeah Pharmaceutical is involved in the distribution of animal health products, including vaccines and therapeutic drugs. The company was formed by integrating the sales functions of Fujita Pharmaceutical and Kyoto Biken, both leaders in the veterinary medicine sector. A wide range of solutions from prevention to treatment is provided through a nationwide network of distributors in Japan. Support services like dosage reminders are also offered to veterinary clinics to ensure timely medication administration.
- Headquarters Shinagawa, Japan
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sasaeah.co.jp
- Acquired by Virbac (Mar 2024)
- Legal Name Sasaeah Pharmaceutical Co., Ltd.
Products & Services of Sasaeah Pharmaceutical
Sasaeah Pharmaceutical offers a comprehensive portfolio of products and services, including Vaccines, Therapeutic Drugs, and Dosage Reminder Service.
Vaccines are provided for preventive animal healthcare solutions.
Therapeutic drugs are offered for treating animal diseases.
Dosage reminders are sent via email to veterinarians.
Investors in Sasaeah Pharmaceutical
Sasaeah Pharmaceutical has secured backing from 1 investor. Prominent investors backing the company include Virbac.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Animal health pharmaceuticals, vaccines, and diagnostics are developed and supplied. | 1968 | virbac.com | Carros, France |
Investor details for Sasaeah Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sasaeah Pharmaceutical
1 people are tracked at Sasaeah Pharmaceutical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Shigeru Taniguchi | CEO | Leadership |
Complete people profiles for Sasaeah Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sasaeah Pharmaceutical
2 dated milestones of Sasaeah Pharmaceutical across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Sasaeah Pharmaceutical is founded.
- Exit Acquired by Virbac.
Web traffic of Sasaeah Pharmaceutical
The website of Sasaeah Pharmaceutical (sasaeah.co.jp) receives about 8.5K visits a month.
- Monthly visits8.5K
▲ 7.4% vs previous month
Websites whose visitors overlap most with Sasaeah Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
vetagent.jp | vetagent.jp | 100% | #1,265,258 | – | |
donavi.ne.jp | donavi.ne.jp | 91% | #628,223 | – | |
| petgo.jp | 85% | 140.6K | #181,503 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sasaeah Pharmaceutical
Sasaeah Pharmaceutical was founded in 2020.
Sasaeah Pharmaceutical is headquartered in Shinagawa, Japan. It is registered at Shinagawa, Tokyo, Japan.
Shigeru Taniguchi is the CEO of Sasaeah Pharmaceutical, as recorded in our data.
Sasaeah Pharmaceutical is involved in the distribution of animal health products, including vaccines and therapeutic drugs. The company was formed by integrating the sales functions of Fujita Pharmaceutical and Kyoto Biken, both leaders in the veterinary medicine sector. A wide range of solutions from prevention to treatment is provided through a nationwide network of distributors in Japan. Support services like dosage reminders are also offered to veterinary clinics to ensure timely medication administration.
Sasaeah Pharmaceutical offers Vaccines, Therapeutic Drugs, and Dosage Reminder Service.
Sasaeah Pharmaceutical has 1 investor. Key investors include Virbac.
Sasaeah Pharmaceutical operates through Sasaeah Pharmaceutical Co., Ltd..
Yes. Sasaeah Pharmaceutical was acquired by Virbac in March 2024.